1
|
Rosai J and Dorfman RF: Sinus
histiocytosis with massive lymphadenopathy: A newly recognized
benign clinicopathologic entity. Arch Pathol. 87:63–70.
1969.PubMed/NCBI
|
2
|
Foucar E, Rosai J and Dorfman R: Sinus
histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease):
Review of the entity. Semin Diagn Pathol. 7:19–73. 1990.PubMed/NCBI
|
3
|
Pitamber HV and Grayson W: Five cases of
cutaneous Rosai-Dorfman disease. Clin Exp Dermatol. 28:17–21. 2003.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Lu CI, Kuo TT, Wong WR and Hong HS:
Clinical and histopathological spectrum of cutanous Rosai-Dorfman
disease in Taiwan. J Am Acad Dermatol. 51:931–939. 2004. View Article : Google Scholar : PubMed/NCBI
|
5
|
Sun NZ, Galvin J and Cooper KD: Cutaneous
Rosai-Dorfman disease successfully treated with low-dose
methotrexate. JAMA Dermatol. 150:787–788. 2014. View Article : Google Scholar : PubMed/NCBI
|
6
|
Brenn T, Calonje E, Granter SR, et al:
Cutaneous Rosai-Dorfman disease is a distinct clinical entity. Am J
Dermatopathol. 24:385–391. 2002. View Article : Google Scholar : PubMed/NCBI
|
7
|
Cangelosi JJ, Prieto VG and Ivan D:
Cutaneous Rosai-Dorfman disease with increased number of
eosinophils: Coincidence or histologic variant? Arch Pathol Lab
Med. 135:1597–1600. 2011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Molina-Garrido MJ and Guillén-Ponce C:
Extranodal Rosai-Dorfman disease with cutaneous and periodontal
involvement: A rare presentation. Case Rep Oncol. 4:96–100. 2011.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Bassis AV, Fairley JA, Ameln RT and Swick
BL: Cutaneous Rosai-Dorfman disease following pneumococcal
vaccination. J Am Acad Dermatol. 65:890–892. 2011. View Article : Google Scholar : PubMed/NCBI
|
10
|
Bunick CG, Leffell D, Bosenberg M, et al:
Cutaneous Rosai-Dorfman disease of the right ear responsive to
radiotherapy. J Am Acad Dermatol. 67:e225–e226. 2012. View Article : Google Scholar : PubMed/NCBI
|
11
|
Fumerton R, Ball N and Zhou Y: Refractory
cutaneous Rosai-Dorfman disease responsive to cryotherapy. Cutis.
87:296–299. 2011.PubMed/NCBI
|
12
|
Fening K, Bechtel M, Peters S, et al:
Cutaneous Rosai-Dorfman disease persisting after surgical excision:
Report of a case treated with acitretin. J Clin Aesthet Dermatol.
3:34–36. 2010.PubMed/NCBI
|
13
|
Chang HS, Son SJ, Cho KH and Lee JH:
Therapeutic challenge of dapsone in the treatment of purely
cutaneous Rosai-Dorfman disease. Clin Exp Dermatol. 36:420–422.
2011. View Article : Google Scholar : PubMed/NCBI
|
14
|
Tjiu JW, Hsiao CH and Tsai TF: Cutaneous
Rosai-Dorfman disease: Remission with thalidomide treatment. Br J
Dermatol. 148:1060–1061. 2003. View Article : Google Scholar : PubMed/NCBI
|
15
|
Oka M, Kamo T, Goto N, et al: Successful
treatment of Rosai-Dorfman disease with low-dose oral
corticosteroid. J Dermatol. 36:237–240. 2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Nadal M, Kervarrec T, Machet MC, et al:
Cutaneous Rosai-Dorfman disease located on the breast: Rapid
effectiveness of methotrexate after failure of topical
corticosteroids, acitretin and thalidomide. Acta Derm Venereol. Jan
29–2015.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
17
|
Gebhardt C, Averbeck M, Paasch U, et al: A
case of cutaneous Rosai-Dorfman disease refractory to imatinib
therapy. Arch Dermatol. 145:571–574. 2009. View Article : Google Scholar : PubMed/NCBI
|